This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Rheum Dis 2004; 63: 974–981.
Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006; 54: 3750–3760.
Khorshid O, Hosing C, Bibawi S, Ueno N, Reveille J, Mayes MD et al. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. J Rheumatol 2004; 31: 2513–2516.
Nash RA, McSweeney PA, Nelson JL, Wener M, Georges GE, Langston AA et al. Allogeneic marrow transplantation in patients with severe systemic sclerosis. Resolution in dermal fibrosis. Arthritis Rheum 2006; 54: 1982–1986.
Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y . Defective vasculogenesis in systemic sclerosis. Lancet 2004; 364: 603–610.
Kottaridis PD, Milligan DW, Chopra R, Chakraverty RK, Chakrabarti S, Robinson S et al. In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation. Blood 2000; 96: 2419–2425.
Wang B, Yamamoto Y, El-Badri NS, Good RA . Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice. Proc Nat Acad Sci USA 1999; 96: 3012–3016.
Slavin S, Nagler A, Varadi G, Or R . Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853–857.
Marmont AM, Gualandi F, van Lint MT, Bacigalupo A . Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 2003; 31: 399–402.
Burt RK, Oyama Y, Verda L, Quigley K, Brush M, Yaung K et al. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum 2004; 50: 2466–2470.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Loh, Y., Oyama, Y., Statkute, L. et al. Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?. Bone Marrow Transplant 39, 435–437 (2007). https://doi.org/10.1038/sj.bmt.1705611
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705611
This article is cited by
-
Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis
Bone Marrow Transplantation (2022)
-
Allogene hämatopoetische Stammzelltransplantation
Zeitschrift für Rheumatologie (2016)
-
Emerging concepts in haematopoietic cell transplantation
Nature Reviews Immunology (2012)
-
Long-term follow-up after nonmyeloablative allogeneic hematopoietic stem cell transplantation for systemic sclerosis
Clinical Rheumatology (2008)